Citigroup’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Sell |
31,328
-21,836
| -41% | -$72.3K | ﹤0.01% | 3659 |
|
|
2025
Q1 | $154K | Sell |
53,164
-5,206
| -9% | -$15.1K | ﹤0.01% | 3573 |
|
|
2024
Q4 | $208K | Buy |
58,370
+1,974
| +4% | +$7.03K | ﹤0.01% | 3562 |
|
|
2024
Q3 | $281K | Buy |
56,396
+39,865
| +241% | +$199K | ﹤0.01% | 3358 |
|
|
2024
Q2 | $43K | Sell |
16,531
-34,692
| -68% | -$90.2K | ﹤0.01% | 3944 |
|
|
2024
Q1 | $218K | Sell |
51,223
-30,954
| -38% | -$132K | ﹤0.01% | 3247 |
|
|
2023
Q4 | $166K | Buy |
+82,177
| New | +$166K | ﹤0.01% | 3259 |
|
|
2022
Q4 | – | Sell |
-410
| Closed | – | – | 4945 |
|
|
2022
Q3 | $0 | Sell |
410
-181
| -31% | – | ﹤0.01% | 4951 |
|
|
2022
Q2 | $0 | Sell |
591
-251
| -30% | – | ﹤0.01% | 5375 |
|
|
2022
Q1 | $2K | Sell |
842
-348
| -29% | -$827 | ﹤0.01% | 5208 |
|
|
2021
Q4 | $5K | Buy |
+1,190
| New | +$5K | ﹤0.01% | 4872 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | – | – | 4977 |
|
|
2021
Q2 | $0 | Sell |
1
-1,314
| -100% | – | ﹤0.01% | 5413 |
|
|
2021
Q1 | $7K | Sell |
1,315
-8,823
| -87% | -$47K | ﹤0.01% | 5129 |
|
|
2020
Q4 | $54K | Buy |
10,138
+8,183
| +419% | +$43.6K | ﹤0.01% | 4035 |
|
|
2020
Q3 | $9K | Sell |
1,955
-1,665
| -46% | -$7.67K | ﹤0.01% | 4357 |
|
|
2020
Q2 | $18K | Buy |
3,620
+46
| +1% | +$229 | ﹤0.01% | 4310 |
|
|
2020
Q1 | $8K | Buy |
3,574
+2,965
| +487% | +$6.64K | ﹤0.01% | 4681 |
|
|
2019
Q4 | $4K | Sell |
609
-49
| -7% | -$322 | ﹤0.01% | 4905 |
|
|
2019
Q3 | $2K | Sell |
658
-359
| -35% | -$1.09K | ﹤0.01% | 4940 |
|
|
2019
Q2 | $4K | Sell |
1,017
-2,645
| -72% | -$10.4K | ﹤0.01% | 4914 |
|
|
2019
Q1 | $25K | Buy |
3,662
+2,785
| +318% | +$19K | ﹤0.01% | 4417 |
|
|
2018
Q4 | $6K | Sell |
877
-583
| -40% | -$3.99K | ﹤0.01% | 4720 |
|
|
2018
Q3 | $26K | Buy |
+1,460
| New | +$26K | ﹤0.01% | 4411 |
|